Insider Transactions in Q4 2022 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Dec 16                          
            2022                          
           | Terry J Rosen Chief Executive Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              13,043
              -2.57%
           | 
              $391,290              
              $30.95 P/Share              
           | 
| 
            Dec 16                          
            2022                          
           | Juan C. Jaen President | 
              SELL
             
                Open market or private sale
             | Direct | 
              4,436
              -1.0%
           | 
              $133,080              
              $30.95 P/Share              
           | 
| 
            Dec 16                          
            2022                          
           | Jennifer Jarrett Chief Operating Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              16,482
              -5.1%
           | 
              $494,460              
              $30.95 P/Share              
           | 
| 
            Dec 16                          
            2022                          
           | Carolyn C. Tang General Counsel | 
              SELL
             
                Open market or private sale
             | Direct | 
              2,523
              -4.1%
           | 
              $75,690              
              $30.95 P/Share              
           | 
| 
            Dec 16                          
            2022                          
           | Ii Robert C. Goeltz Chief Financial Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              2,453
              -8.99%
           | 
              $73,590              
              $30.95 P/Share              
           |